Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment

Michael M Farag,1 Nevine S Abd El Malak,1,2 Soad A Yehia,1 Mohammed A Ahmed1,2 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy, New Giza University, Giza, EgyptCorrespondence: Michael M FaragDepartment of Pharmaceutics an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Farag MM, Abd El Malak NS, Yehia SA, Ahmed MA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/d72ef7a85e5746698fa0de9f02c59556
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d72ef7a85e5746698fa0de9f02c59556
record_format dspace
spelling oai:doaj.org-article:d72ef7a85e5746698fa0de9f02c595562021-12-02T13:50:53ZHyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment1178-2013https://doaj.org/article/d72ef7a85e5746698fa0de9f02c595562021-02-01T00:00:00Zhttps://www.dovepress.com/hyaluronic-acid-conjugated-metformin-phospholipid-sonocomplex-a-biphas-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Michael M Farag,1 Nevine S Abd El Malak,1,2 Soad A Yehia,1 Mohammed A Ahmed1,2 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy, New Giza University, Giza, EgyptCorrespondence: Michael M FaragDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, EgyptTel +002-01228150250Email michael.farag@pharma.cu.edu.egPurpose: Development of hyaluronic acid conjugated metformin-phospholipid sonocomplexes (HA-MPS), a biphasic complexation product compiled for enhancing both the lipophilicity and targeting potential of Metformin (MET) to CD44 receptors on pancreatic cancer.Methods: MET was chemically conjugated to hyaluronic acid (HA) via amide coupling reaction. Then, the HA conjugated MET was physically conjugated to Lipoid™S100 via ultrasound irradiation. A combined D-optimal design was implemented to statistically optimize formulation variables. The HA-MPS were characterized through solubility studies, partition coefficient, drug content uniformity, particle size and zeta potential. The optimized HA-MPS was tested via proton nuclear magnetic resonance, infrared spectroscopy to elucidate the nature of physicochemical interactions in the complex which was further scrutinized on molecular level via molecular docking and dynamic simulation.Results: The solubility and partition studies showed a lipophilicity enhancement up to 67 folds as they adopted inverted micelles configuration based on the packing parameter hypothesis. The optimized HA-MPS showed 11.5 folds lower IC50, extra 25% reduction in oxygen consumption rate, better reduction in hypoxia-inducible factor and reactive oxygen species in MiaPaCa-2 cells.Conclusion: These results proved better internalization of MET which was reflected by abolishing hypoxic tumour microenvironment, a mainstay toward a normoxic and less resistant pancreatic cancer.Keywords: metformin, pancreatic ductal adenocarcinoma, hypoxia-inducible factor, MiaPaCa-2, hyaluronic acidFarag MMAbd El Malak NSYehia SAAhmed MADove Medical Pressarticlemetforminpancreatic ductal adenocarcinomahypoxia-inducible factormiapaca-2hyaluronic acid.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 1005-1019 (2021)
institution DOAJ
collection DOAJ
language EN
topic metformin
pancreatic ductal adenocarcinoma
hypoxia-inducible factor
miapaca-2
hyaluronic acid.
Medicine (General)
R5-920
spellingShingle metformin
pancreatic ductal adenocarcinoma
hypoxia-inducible factor
miapaca-2
hyaluronic acid.
Medicine (General)
R5-920
Farag MM
Abd El Malak NS
Yehia SA
Ahmed MA
Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment
description Michael M Farag,1 Nevine S Abd El Malak,1,2 Soad A Yehia,1 Mohammed A Ahmed1,2 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2School of Pharmacy, New Giza University, Giza, EgyptCorrespondence: Michael M FaragDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, EgyptTel +002-01228150250Email michael.farag@pharma.cu.edu.egPurpose: Development of hyaluronic acid conjugated metformin-phospholipid sonocomplexes (HA-MPS), a biphasic complexation product compiled for enhancing both the lipophilicity and targeting potential of Metformin (MET) to CD44 receptors on pancreatic cancer.Methods: MET was chemically conjugated to hyaluronic acid (HA) via amide coupling reaction. Then, the HA conjugated MET was physically conjugated to Lipoid™S100 via ultrasound irradiation. A combined D-optimal design was implemented to statistically optimize formulation variables. The HA-MPS were characterized through solubility studies, partition coefficient, drug content uniformity, particle size and zeta potential. The optimized HA-MPS was tested via proton nuclear magnetic resonance, infrared spectroscopy to elucidate the nature of physicochemical interactions in the complex which was further scrutinized on molecular level via molecular docking and dynamic simulation.Results: The solubility and partition studies showed a lipophilicity enhancement up to 67 folds as they adopted inverted micelles configuration based on the packing parameter hypothesis. The optimized HA-MPS showed 11.5 folds lower IC50, extra 25% reduction in oxygen consumption rate, better reduction in hypoxia-inducible factor and reactive oxygen species in MiaPaCa-2 cells.Conclusion: These results proved better internalization of MET which was reflected by abolishing hypoxic tumour microenvironment, a mainstay toward a normoxic and less resistant pancreatic cancer.Keywords: metformin, pancreatic ductal adenocarcinoma, hypoxia-inducible factor, MiaPaCa-2, hyaluronic acid
format article
author Farag MM
Abd El Malak NS
Yehia SA
Ahmed MA
author_facet Farag MM
Abd El Malak NS
Yehia SA
Ahmed MA
author_sort Farag MM
title Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment
title_short Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment
title_full Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment
title_fullStr Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment
title_full_unstemmed Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment
title_sort hyaluronic acid conjugated metformin-phospholipid sonocomplex: a biphasic complexation approach to correct hypoxic tumour microenvironment
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/d72ef7a85e5746698fa0de9f02c59556
work_keys_str_mv AT faragmm hyaluronicacidconjugatedmetforminphospholipidsonocomplexabiphasiccomplexationapproachtocorrecthypoxictumourmicroenvironment
AT abdelmalakns hyaluronicacidconjugatedmetforminphospholipidsonocomplexabiphasiccomplexationapproachtocorrecthypoxictumourmicroenvironment
AT yehiasa hyaluronicacidconjugatedmetforminphospholipidsonocomplexabiphasiccomplexationapproachtocorrecthypoxictumourmicroenvironment
AT ahmedma hyaluronicacidconjugatedmetforminphospholipidsonocomplexabiphasiccomplexationapproachtocorrecthypoxictumourmicroenvironment
_version_ 1718392467418513408